Poster Presentations
The poster presentations for INHSU 2023 are grouped into themes. Click on the headings/arrows below to view the presentations from each theme.
To view the abstract, click on the title of the presentation.
Themes
Epidemic analysis of HIV prevalence among men and women who use drugs in Gombe State.
Speaker: Aniedi Akpan, Drug Free And Preventive Healthcare Organization (DAPHO), Nigeria
Speaker: Lucy Attwood, Alfred Health & Monash University, Australia
Speaker: Nina Auestad, Oslo Municipality, Norge
Hepatitis C virus reinfection in a real-world cohort of homeless-experienced individuals in Boston
Speaker: Marguerite Beiser, Boston Health Care For The Homeless Program, United States
Speaker: Claudia Bernardini, Arud, Switzerland
Speaker: Joaquin Cabezas, University Hospital Marques De Valdecilla, Spain
Speaker: Joanne Carson, The Kirby Institute, UNSW Sydney, Australia
Speaker: Charlotte Cook, University Of Southampton, United Kingdom
Speaker: Evan Cunningham, Kirby Institute, Unsw Sydney, Australia
Speaker: Alejandro De La Hoz Gomez, Boston Medical Center, United States
Testing and linkage to care for viral hepatitis in patients admitted for psychiatric care.
Speaker: Sandra Dröse, Department of Clinical research, Faculty of Health Sciences, University of Southern Denmark,, Denmark
Speaker: Benjamin Eckhardt, NYU School of Medicine/Bellevue Hospital, United states
Speaker: Zibs-Godwin Faith, Bayelsa State Drug Abuse Prevention And Rehabilitation Committee(badaparc), Nigeria
Persistent inequities in HCV outcomes for people with HIV who inject drugs engaged in HIV care
Speaker: Oluwaseun Falade-Nwulia, Johns Hopkins University School of Medicine, United States
Speaker: Sarah Gander, NB Social Pediatrics, Canada
Speaker: Marie-Ève Goyer, ESCODI, CIUSSSCSMTL, Canada
A guide to using extended-release buprenorphine (Sublocade®) in opioid agonist therapy (OAT).
Speaker: Marie-Ève Goyer, ESCODI, CIUSSSCSMTL, Canada
Partner injection as a correlate of hepatitis C among justice-involved women in one US state.
Speaker: Jennifer Havens, University Of Kentucky College Of Medicine, United States
Speaker: Eveline Hofman, University Hospital Bern, Switzerland
Speaker: Martin Kåberg, Beroendecentrum Stockholm, Sweden
Speaker: Christian Marcoux, HepCURE Inc., Canada
Speaker: Christian Marcoux, HepCURE Inc., Canada
Speaker: Stephanie Marsan, Centre Hospitalier de l’Université De Montréal, Canada
Real-world hepatitis C cure rates in opioid use disorder from a statewide elimination program.
Speaker: Frederic Mccall, Louisiana Derpartment of Health, United States
Speaker: Matthew Murphy, Brown University, United States
Speaker: Kate Newcombe, Liver Clinic – CUPS, Canada
Speaker: Georgi Pecev, UNIL – Faculté de Biologie et de Médecine, Switzerland
Speaker: Charlotte Meinich Pihl, Agency For Social And Welfare Services, Oslo, Norge
Speaker: Carrie Richardson, The Hepatitis C Trust, United Kingdom
Speaker: Cayley Russell, University Of Toronto/Centre For Addiction And Mental Health (camh), Canada
Speaker: Andrew Scheibe, TB HIV Care, South Africa
Speaker: Andrew Seaman, Oregon Health And Sciences University / Central City Concern, United States
Speaker: Andrew Seaman, Oregon Health And Sciences University / Central City Concern, United States
Speaker: Isaac Thom Shawa, University Of Derby, United Kingdom
FIBROSIS STAGING IN YOUNG PWUD WITH HCV IS UNLIKELY TO CHANGE MANAGEMENT
Speaker: Hunter Spencer, Oregon Health & Science University, United States
Persistent barriers to hepatitis C treatment despite peer support: A mixed methods analysis.
Speaker: Hunter Spencer, Oregon Health & Science University, United States
Speaker: Hunter Spencer, Oregon Health & Science University, United States
Speaker: Catherine Wilson, Greater Glasgow And Clyde, United Kingdom
Speaker: Catherine Wilson, Greater Glasgow And Clyde, United Kingdom
Speaker: Jordan Akerley, End Hep C SF, United States
Speaker: Matthew Akiyama, Albert Einstein College of Medicine, United States
Speaker: Matthew Akiyama, Albert Einstein College of Medicine, United States
Viral hepatitis and HIV risk among older vs younger people who inject drugs in Kenya
Speaker: Matthew Akiyama, Albert Einstein College of Medicine, United States
Cost of Hepatitis C Virus self-testing in Malaysia: A micro-costing study
Speaker: Asra Asgharzadeh, Bristol University, United Kingdom
Speaker: Tamara Barnett, Cool Aid Community Health Center, Canada
The role of whole genome sequencing in revealing an HCV outbreak in Northern Ireland.
Speaker: Daniel Bradshaw, UK Health Security Agency, United Kingdom
Speaker: Andrea Bregenzer, Abbvie Ag, Switzerland
Speaker: Andrea Bregenzer, Abbvie Ag, Switzerland
Speaker: Joaquin Cabezas, University Hospital Marques De Valdecilla, Spain
Disrupting generational trauma through advocacy, support, and connection.
Speaker: Sarah Campbell, Horizon Health Network, Canada
Speaker: Sarah Campbell, Horizon Health Network, Canada
Speaker: Alexandra Collins, Brown University School Of Public Health, United States
Laws restricting access to opioid treatment programs – a typology in the United States
Speaker: Anna Conway, Kirby Institute, Unsw, Australia
Data and Evidence to Drive Hepatitis B and C Service Scale-up
Speaker: Colleen Daniels, Harm Reduction International, United Kingdom
Speaker: Joshua Dawe, University of Bristol, United Kingdom
Speaker: Bridget Draper, Burnet Institute, Australia
Wholistic conversations on the liver and hepatitis C: A visual Indigenous wellness perspective.
Speaker: Kate Dunn, University Of Toronto, Canada
Speaker: Helen Dwyer, UKHSA, United Kingdom
Speaker: Helen Dwyer, UKHSA, United Kingdom
Speaker: Helen Dwyer, UKHSA, United Kingdom
Speaker: James Eghaghe, Equal Health and Rights Access Advocacy Initiative -EHRAAI, Nigeria
Speaker: Thorgerdur Einarsdottir, University Of Iceland, Iceland
Speaker: Shelley Facente, Facente Consulting, United States
Speaker: Honoria Guarino, Cuny Graduate School Of Public Health And Health Policy, United States
Speaker: Lasha Gulbiani, Health Research Union, Georgia
Speaker: Louise Hansford, Hep C U Later (Inclusion MPFT), UK
Speaker: Laura Harkness, Dalhousie Medicine New Brunswick, Canada
Speaker: Margaret Hellard, Burnet Institute, Australia
Speaker: Stine Bordier Høj, Centre hospitalier de l’Université de Montréal, Canada
Use of expert knowledge elicitation methods for monitoring purposes: the PEOPLE project.
Speaker: Blanca Iciar Indave Ruiz, EMCDDA, Portugal
Community-based HCV treatment model for PWIDs in Ukraine’s war emergency.
Speaker: Zahedul ISLAM, Alliance for Public Health, Ukraine
Effect of pre-exposure prophylaxis on the prevention of HIV/AIDS in the city of Douala.
Speaker: NKOMBOU TCHAPON JAURES JIMYTRY, Alcondoms Cameroun, Cameroon
Speaker: Amy Jessop, HepTREC at Prevention Point Philadelphia, United States
HBV Actions in US Harm Reduction Organizations: Perspectives from the Field
Speaker: Amy Jessop, HepTREC at Prevention Point Philadelphia, United States
Speaker: Amy Jessop, HepTREC at Prevention Point Philadelphia, United States
Speaker: Amy Jessop, HepTREC at Prevention Point Philadelphia, United States
Integrating Harm Reduction Services into a State-Wide Substance Use Disorder System of Care
Speaker: Ashly Jordan, New York State Office of Addiction Services and Supports, United States
Population size estimation of people who inject drugs in Georgia.
Speaker: George Kamkamidze, Clinic Neolab, Georgia
Speaker: Giorgi Kanchelashvili, Health Research Union, Georgia
Speaker: Mohammad Karamouzian, University of Toronto, Canada
Speaker: Mohammad Karamouzian, University of Toronto, Canada
Speaker: Mohammad Karamouzian, University of Toronto, Canada
Speaker: Jordan Killion, University Of California, San Diego, United States
Speaker: Marika Kochlamazashvili, Health Research Union, Georgia
Gender differences in hepatitis C exposure and care cascade among people who inject drugs
Speaker: Sarah Larney, Université De Montréal, Canada
Measuring hepatitis C and HIV incidence in people who inject drugs during the COVID-19 pandemic
Speaker: Sarah Larney, Université De Montréal, Canada
Incidence rate of hepatitis C virus infection in the prison setting: The STOP-C study.
Speaker: Andrew Lloyd, The Kirby Institute, Australia
Speaker: Gisela Macphail, CUPS Liver Clinic, Canada
Overdose prevention centers in the United States: A multi-level evaluation.
Speaker: Brandon Marshall, Brown University School Of Public Health, United States
Speaker: Brandon Marshall, Brown University School Of Public Health, United States
Speaker: Pedro Mateu-Gelabert, CUNY – School Of Public Health, United States
Speaker: Pedro Mateu-Gelabert, CUNY – School Of Public Health, United States
Speaker: Anna Meteliuk, Alliance For Public Health, Украина
Speaker: Holly Mitchell, UK Health Security Agency, United Kingdom
Speaker: Amber Newbigging-lister, Senior surveillance and prevention scientist, United Kingdom
Speaker: Amber Newbigging-lister, Senior surveillance and prevention scientist, United Kingdom
Speaker: JEANNE D’ARC NIYOMWUNGERE, Association Burundaise Pour Un Monde De Paix Sans Drogues /abmpd, Burundi
Speaker: Shayla Nolen, Brown University School Of Public Health, United States
Hepatitis C Virus among Patients Visiting a Sexually Transmitted Infections Clinic
Speaker: Amy Nunn, Rhode Island Public Health Institute, Brown University, United States
Speaker: Alisa Pedrana, Burnet Institute, Australia
Speaker: Alisa Pedrana, Burnet Institute, Australia
Speaker: Joana Pires, NOVA National School Of Public Health, Universidade Nova De Lisboa, Portugal
Skin infections in people who use drugs: Learnings from a mixed-methods survey in Wales, 2023
Speaker: Amy Plimmer, Public Health Wales, United Kingdom
Speaker: Olivia Price, National Drug And Alcohol Research Centre, Australia
Speaker: Phillip Read, Kirketon Road Centre, Australia
Speaker: Maria-Bernarda Requena, Iplesp, France
Speaker: Elana Rosenthal, Institute of Human Virology, University of Maryland School of Medicine, United States
Speaker: Thomas Santo Jr, NDARC, UNSW Sydney, Australia
Speaker: Thomas Santo Jr, NDARC, UNSW Sydney, Australia
Speaker: Heidar Sharafi, Research Centre, Centre Hospitalier de l’Université de Montréal (CRCHUM), Canada
Speaker: Sanjeev Sirpal, Vitalite Health Network, University Of Montreal, Canada
Speaker: Alessandro Soria, Fondazione IRCCS San Gerardo Dei Tintori, Italy
Speaker: Jack Stone, University Of Bristol, United Kingdom
Speaker: Jack Stone, University Of Bristol, United Kingdom
Speaker: Jack Stone, University Of Bristol, United Kingdom
A prison-tailored monitoring and evaluation framework for viral hepatitis B and C in the EU
Speaker: Lara Tavoschi, University of Pisa, Italia
Speaker: Angela Thiongo, Medecins Sans Frontieres (MSF), Kenya
Speaker: Félicien Yomi TIA, PROGRAMME NATIONAL DE LUTTE CONTRE LE TABAGISME, L’ALCOOLISME, LA TOXICOMANIE ET LES AUTRES ADDICTIO, Côte d’Ivoire
Speaker: Shane Tillakeratne, The Kirby Institute, Unsw, Australia
Speaker: Sasha Udhesister, Université De Montréal, Canada
Prevalence of Hepatitis C among People Who Inject Drugs in New York State
Speaker: Tomoko Udo, University At Albany, School Of Public Health, United States
Speaker: Farzaneh Vakili, Université de Montréal, Canada
Speaker: Heather Valerio, The Kirby Institute, Australia
Assessing Hepatitis C testing and treatment uptake among PWID in Georgia
Speaker: Annette Verster, WHO, Switzerland
Speaker: Kathleen Ward, Drexel University, United States
Speaker: April Young, University Of Kentucky, US
Speaker: Rossitta Yung, Vancouver Infectious Diseases Centre, Canada
Speaker: Ruth Zimmermann, Robert Koch Institut, Germany
Speaker: Liza Abraham, PATHOntario, Canada
Speaker: Liza Abraham, PATHOntario, Canada
Speaker: Emily Adamson, Burnet Institute, Australia
Speaker: Marianne Alanko Blomé, Department Of Infectious Diseases, Skåne University Hospital, Malmö, Sweden, Sweden
Speaker: Tamara Barnett, Cool Aid Community Health Center, Canada
Speaker: Tamara Barnett, Cool Aid Community Health Center, Canada
Speaker: Margaret Bourke, Castle Street Clinic, Ireland
Speaker: Tracey Brown, Justice Health And Forensic Mental Health Network, Australia
Hepatitis B and C health promotion and prison to community follow up in South Western Uganda.
Speaker: Arafat Bwambale, GREAT LAKES PEACE CENTRE, Uganda
MANAS, a Peer-Led Project Among Women Using Drugs and Engaging in Sex Work
Speaker: Joana Canedo, EuroNPUD, Portugal
Speaker: Paula Carriço, Cri Coimbra, Portugal
A comprehensive approach to homeless people with addictions in an emergency shelter in Lisbon.
Speaker: Raquel Carvalheiro, Ares do Pinhal, Portugal
New approaches to HCV diagnosis and treatment initiation in a mobile outreach program in Lisbon.
Speaker: Raquel Carvalheiro, Ares do Pinhal, Portugal
Speaker: Erika Castro Batänjer, Private Practice, Suisse
Speaker: Jasna Černoša, Clinic For Infectious Diseases And Febrile Illnesses Ljubljana, Slovenia
Impact of an Innovative Community-Based Contracted Pharmacy on HCV Elimination in New Jersey, USA
Speaker: Corey DeStefano, North Jersey Community Research Initiative (njcri), United States
Understanding Hepatitis C Reinfection and Factors Associated with HCV Infection in New Jersey, USA.
Speaker: Corey DeStefano, North Jersey Community Research Initiative (njcri), United States
Safer supply enables life: Expanding the continuum of care for people who use drugs
Speaker: Melisa Dickie, CATIE, Canada
In-person interactions impact on HCV, HIV, and Syphilis Rates in At Risk Populations
Speaker: Pam Ford, Omega Nurses/SRx Health Solutions, Canada
Speaker: Carrie Fowlie, Hepatitis Australia, Australia
CUPS Liver Clinic Conjoint Care Model to support connection to HCV care in Calgary, Alberta, Canada
Speaker: Nicola Gale, CUPS Liver Clinic, Canada
Parent-Child Assistance Program (PCAP).
Speaker: Sarah Gander, NB Social Pediatrics, Canada
Speaker: Janeth Godfrey Godfrey, Serve Tanzania ( SETA), Tanzania, United Republic of
Supplementing hard to reach health services in Oslo – A mobile outreach model.
Speaker: Maria Helseth Greve, Foundation of Franciscan Aid, Nurses On Wheels, Norge
French remote support services for chemsexers – A polyvalent tool to harm reduction.
Speaker: Kaj Hamelin, Aides, France
Inclusion (part of Midlands Partnership Foundation Trust) Hepatitis C (HCV) elimination.
Speaker: Louise Hansford, Hep C U Later (Inclusion MPFT), UK
Speaker: Louise Hansford, Hep C U Later (Inclusion MPFT), UK
Utilizing the patient search tool to find people with untreated hepatitis C in primary care.
Speaker: Louise Hansford, Hep C U Later (Inclusion MPFT), UK
Speaker: Jennifer Havens, University Of Kentucky College Of Medicine, United States
Life after Hepatitis C – An Education Package
Speaker: Gail Hawthorne, Castle Street Clinic, Ireland
Speaker: Sathya Herath, National STD/AIDS Control Program, Sri Lanka
Speaker: Sathya Herath, National STD/AIDS Control Program, Sri Lanka
Female sexual and reproductive health clinic in an addiction clinic- can it be done?
Speaker: Lina Hijazi, Arud, Center for Addiction Medicine, Switzerland
Speaker: KO KO HLAING, United Nations Office On Drugs And Crime (UNODC), Myanmar, Myanmar
A repeat, high-intensity, peer-led testing intervention in community pharmacy
Speaker: Paul Huggett, The Hepatitis C Trust, United Kingdom
Reasons for a high drop-out of opioid agonist therapy (OAT) among clients in Mbeya, Tanzania.
Speaker: Damali Lucas Kabwali, Henry Jackson Foundation, Medical Research International ( Hjfmri Tanzania), Tanzania
Harm Reduction and Recovery in the UK: lessons learnt, hope for the future.
Speaker: Tracey Kemp, Change Grow Live, United Kingdom
Paving the Way for the Future: An Integrated Approach to Hepatitis C Elimination and Its Longevity.
Speaker: Tracey Kemp, Change Grow Live, United Kingdom
Sustaining the elimination of hepatitis C among people who continue to inject drugs.
Speaker: Tracey Kemp, Change Grow Live, United Kingdom
Speaker: Tracey Kemp, Change Grow Live, United Kingdom
Environments of shelter for womxn who use drugs.
Speaker: Lexuri Ledesma, Metzineres, Spain
Programme to eliminate hepatitis C in a network of 49 prisons through multi-stakeholder partnership.
Speaker: Arran Ludlow-rhodes, Gilead Sciences, United Kingdom
Screening and Treatment of Hepatitis C in Cork Prison
Speaker: Conor McGarry, Portlaoise Prison, Ireland
MPACT: Methadone Patient Access to Collaborative Treatment.
Speaker: Beth Meyerson, University Of Arizona College of Medicine, Harm Reducton Research Lab, United States
Choice of HCV testing pathway in prisons is not a barrier to freedom from HCV.
Speaker: Louise Missen, Gilead Sciences, United Kingdom
Peer-led, point of care RNA testing for people experiencing homelessness
Speaker: Danny Morris, The Hepatitis C Trust, United Kingdom
Overdose safety helpline during the COVID-19 pandemic – A promising new service & lessons learned.
Speaker: Stephen Murray, Boston Medical Center, United States
Community prevention against organized crime.
Speaker: Kennedy Mutale, Decisive Minds, Zambia
Speaker: Mohammed Mwakazi, County Government Of Mombasa, Kenya, Kenya
Community screening during ISW (International Screening Week) among drug users in Burundi
Speaker: Armand Nsababaganwa, Bapud, Burundi
Speaker: Joss O’Loan, Kombi Clinic, Australia
Outreach and engagement to achieve hepatitis C micro-elimination in Cairns, Australia.
Speaker: Alisa Pedrana, Burnet Institute, Australia
Speaker: Michelle Pittman, River Stone Recovery Centre, Canada
Speaker: Juliette Pont, SOS Hépatites Bourgogne Franche-Comté, France
arpa-chemsex project (enhanced multidisciplinary network support-chemsex project in France).
Speaker: Jonathan Rayneau, Federation Addiction, France
Speaker: Farah Riazi, The REACH Program at Mount Sinai Hospital, United States
Speaker: Katelyn Roberts, Sanctum Care Group Inc., Canada
Speaker: Ahmed Mohamed Said, Kwale Network of People Who Use Drugs, Kenya
Speaker: Ahmed Mohamed Said, Kwale Network of People Who Use Drugs, Kenya
Speaker: Kathi Scholz, Central Outreach Wellness Center, United States
Speaker: Julia Sheehan, The Hepatitis C Trust, United Kingdom
Speaker: Ben Stone, Sheffield Teaching Hospitals NHS Foundation Trust, United Kingdom
Speaker: Isabella Sunkes, School of Public Health, University At Albany, United States
Speaker: Moise Wadjo Noupa, Alcondoms Cameroon, Cameroon
Speaker: Oliver Wehrli, Arud Centre For Addiction Medicine, Schweiz
Speaker: Brittney Williams, Center On Drug And Alcohol Research, Department Of Behavioral Science, University Of Kentucky College Of Medicine, United States
Implementation of blood borne virus testing in a forensic psychiatric unit
Speaker: Kate Williams, Oxleas NHS Foundation Trust, United Kingdom
Speaker: Rossitta Yung, Vancouver Infectious Diseases Centre, Canada
Barriers to accessing hepatitis C treatment among people who inject drugs.
Speaker: Mojgan Zare, Georgia Harm Reduction Coalition, United States
Speaker: Doris Burtscher, Médecins Sans Frontières, Austria
Speaker: Theresa Caruana, University Of New South Wales – Centre For Social Research In Health, Australia
Speaker: Natalia Fana, New Brunswick Social Pediatrics (nbsp), Canada
Speaker: Guillaume Fontaine, McGill University, Canada
Reimbursing incarcerated individuals for participation in research: A scoping review.
Speaker: Nadine Kronfli, Mcgill University, Canada
Speaker: Sarah Lunney, Horizon Health Network, Canada
Speaker: Beth Meyerson, University Of Arizona College of Medicine, Harm Reducton Research Lab, United States
Speaker: Iryna Mikhnovets, UNODC, Austria
Who will end the drug war? A white paper on the role of relevant stakeholders in Nigeria.
Speaker: Isaac Ogunkola, Youth RISE International, Nigeria
Health Un/Care: Missed Opportunities in Pharmacy Interactions with PWID Seeking Sterile Syringes
Speaker: Danielle Russell, Arizona State University, United States
Speaker: Yumi Sheehan, The Kirby Institute, UNSW SYDNEY, Australia
Speaker: Yumi Sheehan, The Kirby Institute, UNSW SYDNEY, Australia
Assessing Faith-Based Stigma and Discrimination Against People Who Use Drugs in Indonesia.
Speaker: Kiki Marini Situmorang, Community Legal Aid Institute (LBH Masyarakat), Indonesia
Speaker: Olivia Sugarman, Johns Hopkins Bloomberg School Of Public Health, United States
Australian police custody and people who use drugs: Gaps and opportunities
Speaker: Shelley Walker, National Drug Research Institute, Australia